Lv3
240 积分 2025-03-06 加入
CD19 CAR-T cell therapy in a pediatric patient with MDA5+ dermatomyositis and rapidly progressive interstitial lung disease
5小时前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
2天前
已完结
Diagnosis and Management of the Antiphospholipid Syndrome
16天前
已完结
Diagnostic, research, and real-life effect of the 2023 EULAR−ACR classification criteria for antiphospholipid syndrome
16天前
已完结
To B or Not to B — the Role of B-Cell Depletion in Lupus Nephritis
25天前
已完结
Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort
30天前
已完结
Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study
1个月前
已完结
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study
1个月前
已完结
Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study
1个月前
已完结
A new toxicity syndrome in patients with autoimmune disease treated with CAR T-cell therapy
1个月前
已完结
皖公网安备34019202002308
